Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AW91
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003697 | single-stranded DNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 293 | 297 | PF00656 | 0.333 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.532 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.530 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.551 |
CLV_NRD_NRD_1 | 279 | 281 | PF00675 | 0.571 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 310 | 312 | PF00675 | 0.474 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.621 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 309 | 311 | PF00082 | 0.428 |
CLV_PCSK_PC1ET2_1 | 309 | 311 | PF00082 | 0.400 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.510 |
DEG_APCC_DBOX_1 | 3 | 11 | PF00400 | 0.665 |
DEG_APCC_KENBOX_2 | 137 | 141 | PF00400 | 0.615 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.642 |
DOC_MAPK_gen_1 | 309 | 315 | PF00069 | 0.368 |
DOC_PP1_RVXF_1 | 109 | 115 | PF00149 | 0.513 |
DOC_PP2B_LxvP_1 | 88 | 91 | PF13499 | 0.336 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.487 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.683 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.503 |
DOC_USP7_UBL2_3 | 155 | 159 | PF12436 | 0.544 |
DOC_USP7_UBL2_3 | 305 | 309 | PF12436 | 0.328 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.349 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.313 |
LIG_14-3-3_CanoR_1 | 122 | 126 | PF00244 | 0.603 |
LIG_14-3-3_CanoR_1 | 3 | 8 | PF00244 | 0.670 |
LIG_BRCT_BRCA1_1 | 200 | 204 | PF00533 | 0.664 |
LIG_Clathr_ClatBox_1 | 327 | 331 | PF01394 | 0.427 |
LIG_Clathr_ClatBox_1 | 81 | 85 | PF01394 | 0.368 |
LIG_DLG_GKlike_1 | 3 | 10 | PF00625 | 0.665 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.593 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.578 |
LIG_FHA_1 | 264 | 270 | PF00498 | 0.564 |
LIG_FHA_1 | 69 | 75 | PF00498 | 0.342 |
LIG_FHA_2 | 232 | 238 | PF00498 | 0.575 |
LIG_FHA_2 | 291 | 297 | PF00498 | 0.474 |
LIG_LIR_Apic_2 | 298 | 303 | PF02991 | 0.375 |
LIG_LIR_Gen_1 | 190 | 199 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 190 | 195 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 216 | 220 | PF02991 | 0.474 |
LIG_NRBOX | 6 | 12 | PF00104 | 0.468 |
LIG_Pex14_2 | 282 | 286 | PF04695 | 0.628 |
LIG_REV1ctd_RIR_1 | 215 | 221 | PF16727 | 0.452 |
LIG_SH2_STAT5 | 209 | 212 | PF00017 | 0.470 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.545 |
LIG_SUMO_SIM_par_1 | 25 | 31 | PF11976 | 0.355 |
LIG_TRFH_1 | 218 | 222 | PF08558 | 0.532 |
LIG_WRC_WIRS_1 | 264 | 269 | PF05994 | 0.533 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.523 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.604 |
MOD_CK1_1 | 164 | 170 | PF00069 | 0.596 |
MOD_CK1_1 | 178 | 184 | PF00069 | 0.509 |
MOD_CK1_1 | 276 | 282 | PF00069 | 0.678 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.502 |
MOD_CK2_1 | 164 | 170 | PF00069 | 0.607 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.313 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.538 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.496 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.487 |
MOD_GlcNHglycan | 269 | 272 | PF01048 | 0.527 |
MOD_GlcNHglycan | 319 | 322 | PF01048 | 0.408 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.721 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.465 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.415 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.704 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.594 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.482 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.494 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.536 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.401 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.433 |
MOD_NEK2_1 | 5 | 10 | PF00069 | 0.584 |
MOD_PIKK_1 | 153 | 159 | PF00454 | 0.560 |
MOD_PIKK_1 | 161 | 167 | PF00454 | 0.397 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.348 |
MOD_PIKK_1 | 68 | 74 | PF00454 | 0.349 |
MOD_PKA_1 | 3 | 9 | PF00069 | 0.663 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.635 |
MOD_PKA_2 | 147 | 153 | PF00069 | 0.460 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.663 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.460 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.526 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.349 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.313 |
MOD_SUMO_for_1 | 62 | 65 | PF00179 | 0.474 |
TRG_DiLeu_BaEn_1 | 190 | 195 | PF01217 | 0.489 |
TRG_ENDOCYTIC_2 | 325 | 328 | PF00928 | 0.491 |
TRG_ER_diArg_1 | 182 | 184 | PF00400 | 0.621 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.603 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I8F7 | Leptomonas seymouri | 82% | 100% |
A0A0S4IYJ9 | Bodo saltans | 45% | 100% |
A0A1X0NXK3 | Trypanosomatidae | 71% | 100% |
A0A3Q8IB02 | Leishmania donovani | 97% | 100% |
A0A3R7MG63 | Trypanosoma rangeli | 70% | 100% |
A4HCU6 | Leishmania braziliensis | 93% | 100% |
A4I0C7 | Leishmania infantum | 97% | 100% |
C9ZV43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 69% | 100% |
Q4QB87 | Leishmania major | 97% | 100% |
V5BBM3 | Trypanosoma cruzi | 72% | 93% |